Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens
- 7 April 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Psychopharmacology
- Vol. 210 (2), 241-252
- https://doi.org/10.1007/s00213-010-1836-5
Abstract
Kappa opioid receptors (KORs) have been implicated in depressive-like states associated with chronic administration of drugs of abuse and stress. Although KOR agonists decrease dopamine in the nucleus accumbens (NAc), KOR modulation of phasic dopamine release in the core and shell subregions of the NAc—which have distinct roles in reward processing—remains poorly understood. Studies were designed to examine whether the time course of effects of KOR activation on phasic dopamine release in the NAc core or shell are similar to effects on motivated behavior. The effect of systemic administration of the KOR agonist salvinorin A (salvA)—at a dose (2.0 mg/kg) previously determined to have depressive-like effects—was measured on electrically evoked phasic dopamine release in the NAc core or shell of awake and behaving rats using fast scan cyclic voltammetry. In parallel, the effects of salvA on intracranial self-stimulation (ICSS) and sucrose-reinforced responding were assessed. For comparison, a threshold dose of salvA (0.25 mg/kg) was also tested. The active, but not threshold, dose of salvA significantly decreased phasic dopamine release without affecting dopamine reuptake in the NAc core and shell. SalvA increased ICSS thresholds and significantly lowered breakpoint on the progressive ratio schedule, indicating a decrease in motivation. The time course of the KOR-mediated decrease in dopamine in the core was qualitatively similar to the effects on motivated behavior. These data suggest that the effects of KOR activation on motivation are due, in part, to inhibition of phasic dopamine signaling in the NAc core.This publication has 77 references indexed in Scilit:
- Basolateral Amygdala Modulates Terminal Dopamine Release in the Nucleus Accumbens and Conditioned RespondingBiological Psychiatry, 2010
- Dynorphin, stress, and depressionBrain Research, 2010
- Regional specificity in the real‐time development of phasic dopamine transmission patterns during acquisition of a cue–cocaine association in ratsEuropean Journal of Neuroscience, 2009
- Stress and rodent models of drug addiction: role of VTA–accumbens–PFC–amygdala circuitDrug Discovery Today: Disease Models, 2009
- The Kappa-Opioid Agonist U69,593 Blocks Cocaine-Induced Enhancement of Brain Stimulation RewardBiological Psychiatry, 2008
- Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuliNature Neuroscience, 2008
- The structural basis for mapping behavior onto the ventral striatum and its subdivisionsBrain Structure and Function, 2008
- Dynorphin and the pathophysiology of drug addictionPharmacology & Therapeutics, 2007
- Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complexBrain Research Reviews, 2007
- Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodynEuropean Journal of Pharmacology, 2007